Lucid Diagnostics Inc. LUCD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 42.87% | 15.98% | 14.49% | -56.45% | -134.22% |
| Total Depreciation and Amortization | 0.45% | 0.90% | 6.22% | -5.00% | -0.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -700.59% | -79.36% | -6.38% | 14,783.33% | 99.57% |
| Change in Net Operating Assets | -872.43% | 69.94% | -3,706.67% | 93.50% | 2.40% |
| Cash from Operations | -37.65% | 6.64% | 3.79% | -15.47% | -3.26% |
| Capital Expenditure | 19.05% | 90.23% | -321.57% | -82.14% | -12.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 19.05% | 90.23% | -321.57% | -82.14% | -12.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.05% | 206.07% | 275,100.00% | -99.99% | 64.83% |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.07% | 207.02% | 274,250.00% | -99.99% | 64.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -378.78% | 180.95% | 45.92% | -177.90% | 175.43% |